JPMorgan Chase & Co. Issues Positive Forecast for CME Group (NASDAQ:CME) Stock Price

CME Group (NASDAQ:CMEGet Free Report) had its price objective lifted by equities research analysts at JPMorgan Chase & Co. from $209.00 to $212.00 in a report issued on Thursday,Benzinga reports. The brokerage currently has an “underweight” rating on the financial services provider’s stock. JPMorgan Chase & Co.‘s price target suggests a potential downside of 15.56% from the company’s current price.

CME has been the topic of a number of other research reports. Deutsche Bank Aktiengesellschaft cut their target price on shares of CME Group from $227.00 to $226.00 and set a “hold” rating on the stock in a report on Monday, November 11th. Morgan Stanley raised their price target on shares of CME Group from $210.00 to $233.00 and gave the company an “equal weight” rating in a research note on Thursday, October 17th. Keefe, Bruyette & Woods reduced their price objective on CME Group from $260.00 to $256.00 and set a “market perform” rating for the company in a research report on Monday, January 13th. Oppenheimer lifted their target price on CME Group from $245.00 to $258.00 and gave the company an “outperform” rating in a research note on Thursday, October 24th. Finally, Barclays boosted their price target on CME Group from $257.00 to $263.00 and gave the stock an “equal weight” rating in a research report on Thursday. Four research analysts have rated the stock with a sell rating, eight have assigned a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $231.07.

Read Our Latest Stock Analysis on CME

CME Group Stock Up 0.8 %

CME Group stock traded up $2.09 during midday trading on Thursday, hitting $251.05. The stock had a trading volume of 528,308 shares, compared to its average volume of 1,839,613. The business has a fifty day moving average price of $235.74 and a 200 day moving average price of $225.08. CME Group has a 12 month low of $190.70 and a 12 month high of $253.53. The stock has a market cap of $90.47 billion, a P/E ratio of 26.39, a P/E/G ratio of 5.54 and a beta of 0.57. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.09.

CME Group (NASDAQ:CMEGet Free Report) last posted its quarterly earnings results on Wednesday, February 12th. The financial services provider reported $2.52 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.46 by $0.06. CME Group had a return on equity of 13.39% and a net margin of 57.34%. Research analysts predict that CME Group will post 10.18 EPS for the current year.

CME Group declared that its Board of Directors has initiated a stock repurchase plan on Thursday, December 5th that permits the company to buyback $3.00 billion in outstanding shares. This buyback authorization permits the financial services provider to reacquire up to 3.4% of its shares through open market purchases. Shares buyback plans are usually a sign that the company’s leadership believes its stock is undervalued.

Institutional Trading of CME Group

Several institutional investors and hedge funds have recently added to or reduced their stakes in CME. Cerity Partners LLC grew its position in shares of CME Group by 13.8% during the 4th quarter. Cerity Partners LLC now owns 83,014 shares of the financial services provider’s stock worth $18,929,000 after buying an additional 10,097 shares during the period. Quadrant Capital Group LLC raised its position in shares of CME Group by 3.4% during the 4th quarter. Quadrant Capital Group LLC now owns 3,094 shares of the financial services provider’s stock valued at $719,000 after acquiring an additional 101 shares during the last quarter. Ilmarinen Mutual Pension Insurance Co lifted its stake in shares of CME Group by 13.9% in the 4th quarter. Ilmarinen Mutual Pension Insurance Co now owns 110,611 shares of the financial services provider’s stock valued at $25,687,000 after purchasing an additional 13,500 shares during the period. Russell Investments Group Ltd. boosted its position in shares of CME Group by 9.9% in the 4th quarter. Russell Investments Group Ltd. now owns 899,939 shares of the financial services provider’s stock worth $208,941,000 after purchasing an additional 80,755 shares during the last quarter. Finally, Wedbush Securities Inc. grew its stake in shares of CME Group by 11.1% during the fourth quarter. Wedbush Securities Inc. now owns 6,961 shares of the financial services provider’s stock worth $1,616,000 after purchasing an additional 694 shares during the period. 87.75% of the stock is owned by institutional investors.

About CME Group

(Get Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Featured Stories

Analyst Recommendations for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.